Public SEC Form D records
Biotech Form D filings - November 2026
This page lists the 19 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers in November 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 19
- Issuers
- 18
- Combined disclosed
- $786.3M
Directory links
Filing records
19 crawlable filing links in this facet.
- ABVC BIOPHARMA, INC.November 10, 2026 / Reg D 506(b) / CA$3.4M
- InSitu Biologics, Inc.November 10, 2026 / Reg D 506(b) / MN$19.8M
- Aprexis, Inc.November 10, 2026 / Reg D 506(b) / VT$2.2M
- Frontier Bio CorpNovember 10, 2026 / Reg D 506(b) / CA$1.0M
- Chickadee Biomedicines, Inc.November 10, 2026 / Reg D 506(b) / NY$1.0M
- SUTOL BIO, Inc.November 10, 2026 / Reg D 506(b) / MA$474.0K
- Zai Lab LtdNovember 9, 2026 / Reg D 506(b) / MA$249.9M
- NBO Pharma Inc.November 9, 2026 / Reg D 506(c) / NY$7.0M
- Vimy Pharmaceuticals Inc.November 6, 2026 / Reg D 506(b)$278.2K
- ASCENDIA PHARMACEUTICALS, INC.November 6, 2026 / Reg D 506(b) / NJ$4.1M
- Traws Pharma, Inc.November 5, 2026 / Reg D 506(b) / PA$50.0M
- GOA Therapeutics CorpNovember 5, 2026 / Reg D 506(c) / FL$225.0M
- BridgeHealth Pharmaceuticals, Inc.November 5, 2026 / Reg D 506(b) / MA$3.5M
- AI3 Bio, Inc.November 4, 2026 / Reg D 506(b) / MA$48.3M
- AI3 Bio, Inc.November 4, 2026 / Reg D 506(b) / MAUndisclosed
- Rgenta Therapeutics, Inc.November 3, 2026 / Reg D 506(b) / MA$130.1M
- Araceli Biosciences Inc.November 3, 2026 / Reg D 506(b) / OR$4.5M
- Vesalius Longevity Labs Inc.November 3, 2026 / Reg D 506(b)$30.1M
- EVIA Life Sciences Inc.November 2, 2026 / Reg D 506(b)$5.5M